Kandiah_2017_Clin.Interv.Aging_12_697

Reference

Title : Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia - Kandiah_2017_Clin.Interv.Aging_12_697
Author(s) : Kandiah N , Pai MC , Senanarong V , Looi I , Ampil E , Park KW , Karanam AK , Christopher S
Ref : Clin Interv Aging , 12 :697 , 2017
Abstract : Kandiah_2017_Clin.Interv.Aging_12_697
ESTHER : Kandiah_2017_Clin.Interv.Aging_12_697
PubMedSearch : Kandiah_2017_Clin.Interv.Aging_12_697
PubMedID: 28458525

Related information

Citations formats

Kandiah N, Pai MC, Senanarong V, Looi I, Ampil E, Park KW, Karanam AK, Christopher S (2017)
Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia
Clin Interv Aging 12 :697

Kandiah N, Pai MC, Senanarong V, Looi I, Ampil E, Park KW, Karanam AK, Christopher S (2017)
Clin Interv Aging 12 :697